Clinical trial
Treatment of Acute Schizophrenia With Vitamin Therapy
NCT00140166 · Beersheva Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00140166 |
|---|---|
| Title | Treatment of Acute Schizophrenia With Vitamin Therapy |
| Official title | The Treatment of Acute Schizophrenia With High Dose Niacinmide Plus Ascorbate Plus Pyridoxine Plus Centrum Forte vs. Centrum Forte Only as an Add-On to Risperidone and Dietary Counseling |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Collaborators | Supported by a Hilton Family Foundation grant to International Schizophrenia Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Schizophrenia |
| Intervention type | Drug |
| Interventions | niacinamide, pyridoxine, ascorbate |
| Enrollment | 55 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Nov 25, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: